Argus Research Maintains Buy on GE HealthCare Techs, Raises Price Target to $110
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Argus Research analyst David Toung maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $85 to $110.
Argus Research analyst David Toung maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $85 to $110.